Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,485.00
Bid: 2,475.00
Ask: 2,485.00
Change: 30.00 (1.22%)
Spread: 10.00 (0.404%)
Open: 2,435.00
High: 2,490.00
Low: 2,425.00
Prev. Close: 2,455.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Mar 2017 10:39

RNS Number : 7428Y
Morgan Sindall Group PLC
07 March 2017
 

MORGAN SINDALL GROUP plc

(the "Company")

 

Notification of Transactions by Directors

 

The Morgan Sindall 2014 Long Term Incentive Plan (the Plan)

 

Grant of conditional share awards

On 6 March 2017, certain directors of the Company were granted conditional share awards over ordinary shares of 5p each in the capital of the Company ("shares") under the Morgan Sindall 2014 Long Term Incentive Plan ("the Plan").

 

Details of the directors and the number of shares under conditional share awards granted to them under the Plan are set out below:

 

Director

Number of conditional shares awarded

John Morgan

72,636

Steve Crummett

57,918

 

Conditional share awards will normally vest on 6 March 2020 being the third anniversary of the date of grant, subject to continued employment with the Company and satisfaction of the following performance conditions, which are measured over a period of three financial years ending on 31 December 2019:

 

· the number of shares under award representing 100% of the relevant director's salary will be based on a performance condition measuring the Company's earnings per share (EPS). EPS will be expressed in cumulative pence terms and will be equivalent to a growth rate of 6-13% per year over the three-year period; and

 

· the number of shares under award representing 50% of the relevant director's salary will be based on a performance condition measuring the Company's total shareholder return ("TSR") compared with seven of its UK listed peers. TSR will be expressed as an outperformance of median TSR with full vesting for the TSR component requiring 10% per year outperformance of the comparator median.

 

Depending on whether or not the performance conditions are met the directors will receive between 0% and 100% of the award. Details of the performance conditions will be set out in the Directors' Remuneration Report in the Company's 2016 Annual Report (which will be published on or about 27 March 2017).

 

These awards will be subject to a two year holding period on vesting. The base price for calculating the number of conditional shares award was £10.13, the average closing share price between 27 February 2017 and 3 March 2017.

 

No consideration was paid for the grant of the awards.

 

Following the grant of the conditional share awards under the Plan these directors maintain the following beneficial interests in the issued share capital of the Company:

 

Director

Beneficial interest in the shares of the Company

% of the issued share capital of the Company

Total number of shares over which options are held

Total number of conditional share awards held

John Morgan

4,504,352

10.07

106,364

320,630

Steve Crummett

14,615

 0.03

 Nil

248,877

 

This notification relates to transactions notified in accordance with both Disclosure Rule 3.1.4R (1) (a) and Disclosure Rule 3.1.4R (1) (c).

 

 

Contact:

 

Clare Sheridan Tel: 020 7307 9200

Company Secretary

7 March 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFVIVTIDIID
Date   Source Headline
18th Mar 202211:57 amRNSDirector/PDMR Shareholding
16th Mar 20223:03 pmRNSDirector/PDMR Shareholding
16th Mar 20229:23 amRNSDirector/PDMR Shareholding
16th Mar 20229:21 amRNSDirector/PDMR Shareholding
8th Mar 20224:00 pmRNSAdditional Listing
8th Mar 20228:27 amRNSHolding(s) in Company
7th Mar 20221:55 pmRNSDirector/PDMR Shareholding
7th Mar 20221:51 pmRNSDirector/PDMR Shareholding
4th Mar 20224:04 pmRNSDirector/PDMR Shareholding
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 20222:39 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSFinal Results
7th Feb 20227:00 amRNSNotice of Results
1st Feb 202211:41 amRNSTotal Voting Rights
4th Jan 20223:15 pmRNSTotal Voting Rights
21st Dec 202111:42 amRNSDirector Declaration
7th Dec 20212:26 pmRNSAdditional Listing
30th Nov 20214:53 pmRNSTotal Voting Rights
9th Nov 202112:51 pmRNSAdditional Listing
3rd Nov 20217:00 amRNSTrading Update
1st Nov 20219:24 amRNSTotal Voting Rights
20th Oct 202110:57 amRNSBlock listing Interim Review
20th Oct 20218:43 amRNSChange in Directors' Details
7th Oct 20218:44 amRNSAdditional Listing
4th Oct 20213:27 pmRNSHolding(s) in Company
1st Oct 20219:50 amRNSTotal Voting Rights
24th Sep 20218:00 amRNSHolding(s) in Company
22nd Sep 20218:19 amRNSHolding(s) in Company
7th Sep 20211:19 pmRNSAdditional Listing
2nd Sep 20217:26 amRNSHolding(s) in Company
1st Sep 202111:44 amRNSTotal Voting Rights
10th Aug 20213:13 pmRNSAdditional Listing
9th Aug 20214:26 pmRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSHalf-year Report
2nd Aug 20219:37 amRNSTotal Voting Rights
22nd Jul 20217:00 amRNSTrading Update and Outlook for 2021
13th Jul 20217:00 amRNSNotice of Results
1st Jul 20211:22 pmRNSTotal Voting Rights
21st Jun 20215:34 pmRNSHolding(s) in Company
15th Jun 20212:30 pmRNSAdditional Listing
1st Jun 202111:12 amRNSTotal Voting Rights
18th May 20212:00 pmRNSAdditional Listing
6th May 202112:32 pmRNSResult of AGM
6th May 20217:00 amRNSAGM Statement
4th May 20219:05 amRNSTotal Voting Rights
23rd Apr 20213:04 pmRNSHolding(s) in Company
23rd Apr 20218:49 amRNSHolding(s) in Company
22nd Apr 20213:33 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:00 amRNSTrading Update
21st Apr 20219:21 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.